Two GLP-1s (Saxenda and Wegovy) are currently approved for use in adolescents ages 12 and up
Both programs make online GLP-1 access more convenient, though the experience around treatment feels different
Preclinical data further indicate that liraglutide activates the SIRT1 signaling cascade, suppresses atrophy-related genes, and upregulates myogenic differentiation factors, thereby protecting against obesity-induced muscle atrophy and contributing to structural muscle integrity [14, 16]
Notably, NLRP3 activation is strongly associated with IBD (113)
We also translate the cardiovascular story into human termswhy some large trials found fewer heart attacks and strokes and give a reality-check on the brain research so you know whats hopeful and whats hype
Histological and biomechanical recovery were both significantly improved versus controls